Back to results
US 2022/0054466 A1Published application
Pharmaceutical formulations comprising a pyridylaminoacetic acid compound
AssigneeSanten Pharmaceutical Co., Ltd.
InventorsNaveed SHAMS, Henk-Andre KROON, Hisashi KAWATA, Noriko KAWABATA
Life of this patent
Estimating the term…
Abstract
Provided is a pharmaceutical preparation for treatment or prevention of glaucoma or ocular hypertension, comprising 0.0003 to 0.01% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof.
Claims6
A pharmaceutical preparation for treatment or prevention of glaucoma or ocular hypertension, comprising 0.001 to 0.01% (w/v) of isopropyl (6-{[4-(pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)aminomethyl}pyridin-2-ylamino)acetate, or a salt thereof.
Dependencies are inferred from the claim text.